Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Cancer Causes Control. 2008 Aug 15;20(1):27–34. doi: 10.1007/s10552-008-9213-y

Table 2.

Length of Use of Oral Contraceptives and Cancer in the Shanghai Cohort

Cancer Site Number of Months of Use Number of Cases Number of Person-Years RR a 95% CI
All Cancers Combined None 6,669 2,048,373 1.00
1–11 296 133,981 0.88 0.78, 0.99
12–59 384 133,176 0.95 0.85, 1.05
60–119 143 42,602 1.04 0.88, 1.23
120+ 156 42,447 0.99 0.84, 1.16
p = 0.70
Breast None 1,496 2,032,357 1.00
1–11 73 133,492 0.71 0.56, 0.90
12–59 112 132,404 1.04 0.86, 1.27
60–119 34 42,318 0.97 0.69, 1.36
120+ 34 42,033 0.94 0.66, 1.32
p = 0.53
Colon None 563 2,045,338 1.00
1–11 25 134,048 0.97 0.64, 1.47
12–59 32 133,308 0.96 0.67, 1.38
60–119 13 42,625 1.13 0.65, 1.97
120+ 22 42,378 1.56 1.01, 2.40
p = 0.16
Liver None 420 2,047,302 1.00b
1–11 14 134,154 0.86 0.50, 1.48
12–59 16 133,451 0.68 0.41, 1.14
60–119 11 42,639 1.34 0.73, 2.45
120+ 7 42,406 0.67 0.32, 1.44
p = 0.30
Lung None 746 2,048,263 1.00
1–11 25 134,223 0.96 0.64, 1.45
12–59 29 133,484 0.77 0.53, 1.12
60–119 14 42,667 1.05 0.62, 1.79
120+ 14 42,417 0.83 0.49, 1.41
p = 0.29
Ovary None 254 2,008,845 1.00
1–11 22 132,754 1.36 0.87, 2.13
12–59 14 131,891 0.82 0.47, 1.41
60+ 17 84,400 1.44 0.87, 2.39
p = 0.36
Pancreas None 208 2,046,309 1.00
1–11 7 134,161 0.94 0.44, 2.04
12–59 16 133,439 1.46 0.87, 2.46
60+ 7 85,013 0.81 0.37, 1.74
p=0.74
Rectal None 306 2,045,266 1.00
1–11 11 134,064 0.71 0.37, 1.34
12–59 29 133,351 1.54 1.04, 2.29
60–119 12 42,594 1.93 1.08, 3.46
120+ 10 42,373 1.34 0.71, 2.52
p = 0.017
Stomach None 721 2,046,890 1.00
1–11 30 134,167 0.94 0.65, 1.37
12–59 38 133,390 0.96 0.69, 1.33
60–119 14 42,610 1.04 0.61, 1.77
120+ 21 42,390 1.32 0.85, 2.05
p = 0.49
Thyroid None 141 2,044,687 1.00
1–11 5 134,094 0.52 0.21, 1.27
12+ 15 218,289 0.99 0.57, 1.72
p = 0.65
Uterine Corpus None 236 1,982,639 1.00c
1–11 14 131,423 1.15 0.65, 2.01
12+ 13 213,962 0.48 0.27, 0.85
p = 0.015
a

Adjusted for parity and age using linear splines unless otherwise noted

b

Adjusted additionally forever having had a tubal ligation

c

Adjusted additionally for number of induced abortions